tirzepatide side effects
Compare 5 Prescription Weight Loss Drugs: Tirzepatide vs Semaglutide
Compare 5 Prescription Weight Loss Drugs: Tirzepatide vs Semaglutide In Phase III trials, tirzepatide achieved 15% greater average weight loss than semaglutide, while causing early-stage nausea in up to 70% of patients. Both drugs belong to the GLP-1 receptor agonist class and are prescribed for chronic obesity management. Medical Disclaimer: